Protein Phosphatase 2A Interacts with and Directly Dephosphorylates RelA
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Nuclear factor-kappa B (NF-kappa B)/Rel transcription factors are key regulators of a variety of genes involved in inflammatory responses, growth, differentiation, apoptosis, and development. There are increasing lines of evidence that NF-kappa B/Rel activity is controlled to a great extent by its phosphorylation state. In this study, we demonstrated that RelA physically associated with protein phosphatase 2A (PP2A) subunit A (PR65). Both the N- and C-terminal regions of RelA were responsible for the PP2A binding. RelA co-immunoprecipitated with PP2A in melanocytes in the absence of stimulation, indicating that RelA forms a signaling complex with PP2A in the cells. RelA was dephosphorylated by a purified PP2A core enzyme, a heterodimer formed by the catalytic subunit of PP2A (PP2Ac) and PR65, in a concentration-dependent manner. Okadaic acid, an inhibitor of PP2A at lower concentration, increased the basal phosphorylation of RelA in melanocytes and blocked the dephosphorylation of RelA after interleukin-1 stimulation. Interestingly, PP2A immunoprecipitated from melanocytes was able to dephosphorylate RelA, whereas PP2A immunoprecipitated from melanoma cell lines exhibited decreased capacity to dephosphorylate RelA in vitro. Moreover, in melanoma cells in which I kappa B kinase activity was inhibited by sulindac to a similar level as in melanocytes, the phosphorylation state of RelA and the relative NF-kappa B activity were still higher than those in normal melanocytes. These data suggest that the constitutive activation of RelA in melanoma cells (Yang, J., and Richmond, A. (2001) Cancer Res. 61, 4901-4909) could be due, at least in part, to the deficiency of PP2A, which exhibits decreased dephosphorylation of NF-kappa B/RelA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This can be owed to higher PP2A activity in CIP2A deficient cells leading to dephosphorylation of RelA and inactivation of the NF-kB downstream signalling (35,36).”
From Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype (2022) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
Research works printed but not linked: 5
- Rodriguez, 1996, Oncogene, 12, 2425
- Thevenin, 1990, New Biol., 2, 793
- Yang, 2001, Cancer Res., 61, 4901
- Gilmore, 1996, Oncogene, 13, 1367
- Sovak, 1997, J. Clin. Invest., 100, 2952, 10.1172/JCI119848 · DOI · Paper page
Cited by
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496
Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression
Nelson, D. E., Ihekwaba, A. E. C., Elliott, M., Johnson, J. R., Gibney, C. A., Foreman, B. E., Nelson, G., See, V., Horton, C. A., Spiller, D. G., et al. (2004) · Science · doi:10.1126/science.1099962 · Cited by 1,186
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
“Another RelA-interacting factor, protein phosphatase 2A, was implicated in its dephosphorylation (Yang et al., 2001).”
BackgroundSalminen, A., Kauppinen, A., & Kaarniranta, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.006 · Cited by 763
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
“RelA dephosphorylation by protein phosphatase 2A (PP2A) has been reported to decrease NF-κB activity [22].”
NF-κB activation as a pathological mechanism of septic shock and inflammation
Liu, S. F., & Malik, A. B. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00477.2005 · Cited by 761
“Phosphatase 2A (260) and phosphatase 4 (263) dephosphorylate p65 protein.”
Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Giridharan, S., & Srinivasan, M. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s140188 · Cited by 686
“1 has been shown to reduce the interaction of p65 with p300 and thereby inhibit gene expression.(4,63,64) However, much like”
BackgroundSakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., & Saiki, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301598200 · Cited by 377
Self-citationPP2A as a master regulator of the cell cycle
Wlodarchak, N., & Xing, Y. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2016.1143913 · Cited by 371
Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway
Huang, B., Yang, X.-D., Lamb, A., & Chen, L.-F. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.017 · Cited by 343
“Dephosphorylation of RelA might be an important step in re-establishing the normal responsiveness of NF-κB by terminating NF-κB signaling after stimulant removal or target gene expression [40;41].”
BackgroundRegulation of the transcriptional activity of the nuclear factor-κB p65 subunit
Vermeulen, L., De Wilde, G., Notebaert, S., Vanden Berghe, W., & Haegeman, G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01161-9 · Cited by 304
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Eisele, P. S., Salatino, S., Sobek, J., Hottiger, M. O., & Handschin, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375253 · Cited by 187
“We therefore tested whether pharmacological inhibition of protein phosphatase 2A (PP2A) and PP1, two enzymes that dephosphorylate p65 (37), by okadaic acid abolishes the repression of p65 phosphorylation mediated by PGC-1 and PGC-1 in muscle cells.”
Sun, L., Stoecklin, G., Van Way, S., Hinkovska-Galcheva, V., Guo, R.-F., Anderson, P., & Shanley, T. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607347200 · Cited by 184
Targeting Protein Serine/Threonine Phosphatases for Drug Development
McConnell, J. L., & Wadzinski, B. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053140 · Cited by 174
“Like the Ras-Raf1-MEK-ERK pathway, PP2A has been shown to play a crucial regulatory role at many steps in the IKK–NF- B signal transduction pathway (Sun et al., 1995; DiDonato et al., 1997; Yang et al., 2001; Fu et al., 2003; Li et al., 2006).”
BackgroundSelf-citationWIP1 phosphatase is a negative regulator of NF-κB signalling
Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., López-Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172
Yang, J., Amiri, K. I., Burke, J. R., Schmid, J. A., & Richmond, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1220 · Cited by 168
“Experimental protocol for Western blotting of proteins was carried forth as we have previously described (13).”
MethodSelf-citationProtein phosphatase 4 – from obscurity to vital functions
Cohen, P. T. W., Philp, A., & Vázquez-Martin, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.070 · Cited by 161
“However, PP2A has previously been implicated in dephosphorylation of p65, which results in a decrease of transcriptional activity of NF-jB [35].”
BackgroundArctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes
Zhong, Y., Lee, K., Deng, Y., Ma, Y., Chen, Y., Li, X., Wei, C., Yang, S., Wang, T., Wong, N. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12433-w · Cited by 160
Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question
HOOF, C. V., & Goris, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00029-6 · Cited by 176
Gambaryan, S. P., Kobsar, A. L., Rukoyatkina, N., Herterich, S., Geiger, J., Smolenski, A., Lohmann, S. M., & Walter, U. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077602 · Cited by 168
NF-κB in cancer—a friend turned foe
Ravi, R. K., & Bedi, A. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.003 · Cited by 174
“phatase 2A (PP2A) decreases NF- B activity (Yang et al., 2001).”
BackgroundNF-κB as an Integrator of Diverse Signaling Pathways: The Heart of Myocardial Signaling?
Jones, W. K., Brown, M. A., Ren, X., He, S., & McGuinness, M. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:3:229 · Cited by 160
“In opposition to kinase activities, phosphatase 2a dephosphorylates p65 (37).”
Protein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Targeting the NF-κB Pathway in Cancer Therapy
Erstad, D. J., & Cusack, J. C. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.011 · Cited by 152
RNAi Screen in Mouse Astrocytes Identifies Phosphatases that Regulate NF-κB Signaling
Li, S., Wang, L., Berman, M. A., Zhang, Y., & Dorf, M. E. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.015 · Cited by 132
Long, L., Deng, Y., Yao, F., Guan, D., Feng, Y., Jiang, H., Li, X., Hu, P., Lu, X., Wang, H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.015 · Cited by 127
Yeh, P. Y., Yeh, K.-H., Chuang, S.-E., Song, Y. C., & Cheng, A.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402362200 · Cited by 119
PKA, PKC, and the Protein Phosphatase 2A Influence HAND Factor Function
Firulli, B. A., Howard, M. J., McDaid, J. R., McIlreavey, L., Dionne, K. M., Centonze, V. E., Cserjesi, P., Virshup, D. M., & Firulli, A. B. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00425-8 · Cited by 126
“Notably, neither additional B56 family units (Yang et al., 2001).”
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
Perrotti, D., & Neviani, P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9119-x · Cited by 127
“Another PP2A substrate involved in pro-survival signals is Rel A, an NF-κB transcription factor, which has been found physically associated with the PR65/A subunit and whose transactivating activity is diminished upon direct dephosphorylation by PP2A [24].”
BackgroundGSK-3β controls NF-kappaB activity via IKKγ/NEMO
Medunjanin, S., Schleithoff, L.-M., Fiegehenn, C., Weinert, S., Zuschratter, W., & Braun-Dullaeus, R. C. (2016) · Scientific Reports · doi:10.1038/srep38553 · Cited by 130
Bagaev, A., Garaeva, A. Y., Лебедева, Е. С., Av, P., Ataullakhanov, R. I., & Ataullakhanov, F. I. (2019) · Scientific Reports · doi:10.1038/s41598-018-36052-5 · Cited by 125
Murine Electrophysiological Models of Cardiac Arrhythmogenesis
Huang, C. L.-H. (2016) · Physiological Reviews · doi:10.1152/physrev.00007.2016 · Cited by 113
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
Clark, A. R., & Ohlmeyer, M. H. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.016 · Cited by 122
“RelA and promotes its dephosphorylation (Hsieh, Hsiao, Hsu, Wang, & Sheu, 2014; Yang et al., 2001).”
BackgroundGuo, J., Duan, Z., Zhang, C., Wang, W., He, H., Liu, Y., Wu, P. S., Wang, S., Song, M., Chen, H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901104 · Cited by 101
“Previous studies have reported that the gene-encoding PPP2CA, a vital constituent of PP2A, is a target gene of miR-183 (16), and that PPP2CA can dephosphorylate p65 directly (17, 18).”
BackgroundJanssens, V., & Rebollo, A. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218930 · Cited by 93
“In line with its currently well-established tumour suppressor function, PP2A most commonly acts as a pro-apoptotic and anti-survival enzyme, the activity of which is impaired in many cancer settings [4, 19, 57, 68, 82, 108, 139, 141].”
BackgroundInfluentialTumor suppressor functions for the Cdk inhibitor p21 in the mouse colon
Poole, A. J., Heap, D., Carroll, R. E., & Tyner, A. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207994 · Cited by 92
“Disruption of the p21 gene enhanced colon tumor formation in mice with mutations in APC (Yang et al., 2001).”
BackgroundPositive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
Estrada, Y., Dong, J., & Ossowski, L. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00520.x · Cited by 84
“It is still possible that, as previously shown (Yang et al., 2001) PP2A activity, and not expression, is down regulated in melanomas contributing to loss of ERK inhibition by p38.”
BackgroundDephosphorylation of Carma1 by PP2A negatively regulates T‐cell activation
Eitelhuber, A. C., Warth, S. C., Schimmack, G., Düwel, M., Hadian, K., Demski, K., Beisker, W., Shinohara, H., Kurosaki, T., Heissmeyer, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.331 · Cited by 89
“Such direct interactions of the constant regulatory PP2A subunit has also been observed for other substrates, for example the TNFa signalling adapter TRAF2 and the NF-kB family member p65 (Yang et al, 2001; Li et al, 2006).”
BackgroundPrajapati, S., Verma, U., Yamamoto, Y., Kwak, Y. T., & Gaynor, R. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306273200 · Cited by 79
NF-κB in Cardiovascular Disease: Diverse and Specific Effects of a "General" Transcription Factor?
Jones, W. K., Brown, M. A., Wilhide, M. E., He, S., & Ren, X. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:2:183 · Cited by 87
Bott, A., Erdem, N., Lerrer, S., Hotz‐Wagenblatt, A., Breunig, C., Abnaof, K., Wörner, A., Wilhelm, H., Münstermann, E., Ben‐Baruch, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14915 · Cited by 83
“It has been shown that PP2A directly interacts with and dephosphorylates p65 at basal levels and prevents NF-κB translocation to the nucleus in melanoma cells [98].”
BackgroundPositive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A
Kray, A. E., Carter, R. S., Pennington, K. N., Gomez, R. J., Sanders, L. E., Llanes, J. M., Khan, W. N., Ballard, D. W., & Wadzinski, B. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506093200 · Cited by 76
Self-citationShapira, S. D., Harb, O. S., Margarit, J., Matrajt, M., Han, J., Hoffmann, A., Freedman, B. D., May, M. J., Roos, D. S., & Hunter, C. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02428 · Cited by 75
“For example, recent evidence suggests that protein phosphatase 2A (PP2A) is physically associated with the p65/RelA-IκB complex and can dephosphorylate p65/RelA under appropriate conditions (Yang et al., 2001).”
BackgroundRegulation of the RelA (p65) transactivation domain
O'shea, J. M., & Perkins, N. D. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360603 · Cited by 87
Oxidants Positively or Negatively Regulate Nuclear Factor κB in a Context-dependent Manner
Loukili, N. H., Rosenblatt‐Velin, N., Rolli, J., Levrand, S., Feihl, F., Waeber, B., Pacher, P., & Liaudet, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103259 · Cited by 74
Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin
Chassin, C., Hornef, M. W., Bens, M., Lotz, M., Goujon, J.-M., Vimont, S., Arlet, G., Hertig, A., Rondeau, E., & Vandewalle, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071032 · Cited by 70
Human T-Cell Lymphotropic Virus: A Model of NF-κB-Associated Tumorigenesis
Qu, Z., & Xiao, G. (2011) · Viruses · doi:10.3390/v3060714 · Cited by 74
“For example, phosphorylation and acetylation of RelA are reversibly regulated by different phosphatases and histone deacetylases (HDACs) [38,39,41,69–72].”
BackgroundThe Strength of Indecisiveness: Oscillatory Behavior for Better Cell Fate Determination
Lahav, G. (2004) · Science s STKE · doi:10.1126/stke.2642004pe55 · Cited by 69
Milanovic, M., Kracht, M., & Schmitz, M. L. (2013) · Biochemical Journal · doi:10.1042/bj20130780 · Cited by 69
Post-translational modification of RelA(p65) NF-κB
Campbell, K. J., & Perkins, N. D. (2004) · Biochemical Society Transactions · doi:10.1042/bst0321087 · Cited by 62
Guergnon, J., Godet, A. N., Galioot, A., Falanga, P. B., Colle, J., Cayla, X., & García, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.001 · Cited by 65
Association between ADAM33 polymorphisms and adult asthma in the Japanese population
Hirota, T., Hasegawa, K., Obara, K., Matsuda, A., Akahoshi, M., Nakashima, K., Shirakawa, T., Doi, S., Fujita, K., Suzuki, Y., et al. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02522.x · Cited by 57
PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65
Zhang, T., Park, K. A., Li, Y., Byun, H. S., Jeon, J., Lee, Y., Hong, J. H., Kim, J., Huang, S.-M., Choi, S.-W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3062 · Cited by 61
Regulation of cardiac excitation and contraction by p21 activated kinase-1
Ke, Y., Lei, M., & Solaro, R. J. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2009.01.007 · Cited by 54
“1, (ERG1) K+ channels LPA, lysophosphatidic acid MAP kinase, mitogen activated protein kinase MLC20, myosin regulatory light chain MLCK, myosin light chain kinase Mst1, mammalian Ste20-like kinase MyBP-C, myosin binding protein C NCX, sodium/calcium exchanger NFκB, kappa immunoglobulin enhancer-binding protein, a tran…”
BackgroundThe PP2A inhibitor SET regulates natural killer cell IFN-γ production
Trotta, R., Ciarlariello, D., Col, J. D., Allard, J., Neviani, P., Santhanam, R., Mao, H., Becknell, B., Yu, J., Ferketich, A. K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070419 · Cited by 53
Systemic Targeting Inhibitor of κB Kinase Inhibits Melanoma Tumor Growth
Yang, J., Pan, W.-H., Clawson, G. A., & Richmond, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3547 · Cited by 54
“To elucidate the biochemical mechanism of the H-Ras–induced NF-nB activation, IKKa/h were immunoprecipitated from cells with or without H-Ras expression and in vitro kinase assays were done using RelA as a substrate (26).”
MethodSelf-citationChantôme, A., Pance, A., Gauthier, N., Vandroux, D., Chenu, J., Solary, É., Jeannin, J., & Reveneau, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313731200 · Cited by 57
Artificial neural networks enable genome-scale simulations of intracellular signaling
Nilsson, A., Peters, J. M., Meimetis, N., Bryson, B. D., & Lauffenburger, D. A. (2022) · Nature Communications · doi:10.1038/s41467-022-30684-y · Cited by 66
Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer
Lu, X., & Yarbrough, W. G. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.09.003 · Cited by 55
“identified that PP2A directly dephosphorylates RelA [26] and the decreased association of the two in melanoma cells indicates it is a possible mechanism for constitutive activation of RelA in melanoma cells [65].”
BackgroundHaller, D. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00762.x · Cited by 57
PPM1A is a RelA phosphatase with tumor suppressor-like activity
Lu, X., An, H., Jin, R., Zou, M., Guo, Y., Su, P.-F., Liu, D., Shyr, Y., & Yarbrough, W. G. (2013) · Oncogene · doi:10.1038/onc.2013.246 · Cited by 49
Post-translational modifications of p65: state of the art
Sun, X., Cao, S., Mao, C., Sun, F., Zhang, X., & Song, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1417502 · Cited by 50
“…p65 and p300 and exerting a negative regulatory effect on NF-κ B. Similarly, the protein phosphatase 2A (PP2A) was identi fi ed as a dephosphorylating enzyme for p65, revealing speci fi city in dephosphorylating S536 and inhibiting NF-κ B transcriptional activity (Yang et al., 2001; Li et al., 2006).”
BackgroundVitamin E and NF‐κB Activation: A Review
Glauert, H. P. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(07)76006-5 · Cited by 47
Dai, Y., Chen, S., Wang, L., Pei, X., Funk, V. L., Kramer, L. B., Dent, P., & Grant, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284216 · Cited by 47
Association of ADAM33 gene polymorphisms with asthma in Indian children
Awasthi, S., Tripathi, P., Ganesh, S., & Husain, N. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.157 · Cited by 41
Tsuchiya, Y., Osaki, K., Kanamoto, M., Nakao, Y., Takahashi, E., Higuchi, T., & Kamata, H. (2017) · FEBS Letters · doi:10.1002/1873-3468.12912 · Cited by 48
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer
Naderi, A., Liu, J., & Hughes‐Davies, L. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-111 · Cited by 45
“The modulation of PP2A, which is known to regulate several key proteins involved in mitochondrial apoptosis and G1 cell cycle [11,12], provides a possible mechanism to explain the BEX2-mediated cellular effects.”
BackgroundInfluentialBreuer, R., Becker, M. S., Brechmann, M., Mock, T., Arnold, R., & Krammer, P. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533547 · Cited by 40
Yi, F., Liu, S., Luo, F., Zhang, X., & Li, B. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12257 · Cited by 36
“To determine whether PP1 plays a role, we pre-incubated brain slices with the PP1 inhibitor tautomycin for 1 h. Tautomycin could inhibit both PP1 and PP2A, but with a higher affinity for PP1.”
BackgroundSun, L., Pham, T., Cornell, T. T., McDonough, K. L., McHugh, W. M., Blatt, N. B., Dahmer, M. K., & Shanley, T. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600221 · Cited by 35
“In vitro studies demonstrated direct interaction and dephosphorylation by PP2A of IRAK1 (9), IKKa/b/g (10), NF-kB p65 (11), and MAPKs (12, 13).”
BackgroundProduction of chemokine CXCL1/KC by okadaic acid through the nuclear factor-κB pathway
Feng, G., Ohmori, Y., & Chang, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi174 · Cited by 39
Regulation if NF-κB Transcriptional Activity
Vermeulen, L., Berghe, W. V., & Haegeman, G. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_4 · Cited by 39
Protein phosphatases in TLR signaling
Seumen, C. H. T., Grimm, T. M., & Hauck, C. R. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00722-1 · Cited by 35
“Potentially, there are additional targets of PP2A in the TLR signaling cascade, such as IKKα/β/γ [57], IκB-α [58], NFκB p65 [59] and MAPKs [56, 60], which have also been reported to associate with PP2A.”
BackgroundWang, X., Wang, R., Luo, M., Li, C., Wang, H.-X., Huan, C., Qu, Y., Liao, Y., & Mao, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16593 · Cited by 35
“PP2A can also interact with p65 in melanocytes in the absence of stimulation, suggesting p65 can be dephosphorylated by PP2A-C in the cells [65].”
BackgroundFujita, M., Goto, K., Yoshida, K., Okamura, H., Morimoto, H., Kito, S., Fukuda, J., & Haneji, T. (2003) · Oral Oncology · doi:10.1016/s1368-8375(03)00152-0 · Cited by 33
Liu, C., Wang, Q., Zong, D., Pei, S., Yan, Y., Yan, M., Sun, L., Hao, Y.-Y., Mao, M., Xing, W., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.010 · Cited by 32
Shu, G., Zhang, L., Jiang, S., Cheng, Z., Wang, G., Huang, X., & Yang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9603 · Cited by 32
“Ser536-phosphorylated p65 can be dephosphorylated by protein phosphatases such as protein phosphatase 2A (PP2A) [7].”
BackgroundKatayama, K., Yamaguchi, M., Noguchi, K., & Sugimoto, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.007 · Cited by 32
Ruiz, P. A., Kim, S. C., Sartor, R. B., & Haller, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405032200 · Cited by 33
Liu, C., Zhou, Y., Li, M., Wang, Y., Liu, Y., Yang, S., Feng, Y., Wang, Y., Wang, Y., Ren, F., et al. (2019) · Theranostics · doi:10.7150/thno.32451 · Cited by 30
“Serine/threonine protein phosphatase 1 (PP1), PP2A, PP4 and WIP1 [9-12] have been identified to dephosphorylate p65.”
InfluentialHistone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-κB signaling
Xu, C., Tang, J., Yang, Q., Zhao, H., Liu, Y., Cao, J., Zhou, Y., Chen, X., & Chen, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101380 · Cited by 29
“It has been reported that the PPs PP1, PP4 and PP2 could repress the activation of NF-κB signaling by decreasing phosphorylation of IKKβ (9, 10, 13, 21).”
BackgroundSilverstein, A. M., Davis, A. J., Bielinski, V. A., Esplin, E. D., Mahmood, N. A., & Mumby, M. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00168-6 · Cited by 29
Henmi, T., Amano, K., Nagaura, Y., Matsumoto, K., Echigo, S., Tamura, S., & Kobayashi, T. (2009) · Biochemical Journal · doi:10.1042/bj20090208 · Cited by 28
Tristetraprolin and Its Role in Regulation of Airway Inflammation
Prabhala, P., & Ammit, A. J. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095984 · Cited by 30
“cellular functions, including cell growth, inflammation, and apoptosis (Santoro et al., 1998; Yang et al., 2001).”
BackgroundDobson, S., Kumar, R., Bracchi-Ricard, V. C., Freeman, S., Al-Murrani, S. W. K., Johnson, C. D., Damuni, Z., Chakrabarti, D., & Barik, S. (2003) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(02)00293-1 · Cited by 29
Modulation of NF-κB and Nrf2 pathways by lycopene supplementation in heat-stressed poultry
Şahin, K. (2015) · World s Poultry Science Journal · doi:10.1017/s0043933915000288 · Cited by 26
“RelA dephosphorylation by protein phosphatase 2A (PP2A) has been reported to decrease NF-κB activity (Yang et al., 2001).”
BackgroundAdvances in Immunosuppressive Agents Based on Signal Pathway
Xu, Z., & Chu, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.917162 · Cited by 31
Dobierzewska, A., Giltiay, N. V., Sabapathi, S. K., Karakashian, A., & Nikolova‐Karakashian, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238030 · Cited by 21
Sun, L., Hult, E. M., Cornell, T. T., Kim, K. K., Shanley, T. P., Wilke, C. A., Agarwal, M., Gurczynski, S. J., Moore, B. B., & Dahmer, M. K. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00299.2018 · Cited by 22
TRANSCRIPTOMIC EFFECTS OF TET-ON AND MIFEPRISTONE INDUCIBLE SYSTEMS IN MOUSE LIVER
Reboredo, M., Kramer, M. G., Smerdou, C., Prìeto, J., & Rivas, J. D. L. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.057 · Cited by 22
“, 2003), protein phosphatase-2A (Yang et al., 2001), and PARP-1 and C/EBP (Xia et al.”
Qu, L., Ji, Y., Zhu, X. D., & Zheng, X. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv041 · Cited by 20
“Although many detailed mechanisms remain poorly understood, some phosphatases have been identified as regulators of NF-kB signaling, including PP1, PP2A, PP2B, PP2C, and PP4 (Pons and Torres-Aleman, 2000; Yang et al., 2001; Fu et al., 2003; Prajapati et al., 2004; Kray et al., 2005; Li et al., 2008; You et al., 2010;…”
BackgroundN-acetyltransferase 10 promotes cutaneous wound repair via the NF-κB-IL-6 axis
Wang, B., Zhang, J., Li, G., Xu, C., Yang, L., Zhang, J., Wu, Y., Liu, Y., Liu, Z., Wang, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01628-2 · Cited by 20
“Additionally, applying phosphatase inhibitor LB-100, the inhibitor of PP2A which dephosphorylates p65 [31, 32], did not markedly affect the p65 nuclear distribution in HaCaT cells with NAT10 knockdown or not (Fig.”
He, Z., Du, L., Ke, Y., Wen, C., & Zhang, Y. (2019) · Inflammation · doi:10.1007/s10753-019-00962-x · Cited by 19
Hsieh, C., Hsiao, G., Hsu, M., Wang, Y., & Sheu, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12277 · Cited by 15
“This finding is consistent with a previous study showing that PP2A interacts with and directly dephosphorylates RelA in melanoma cells, and they also found OA could restore p65 dephosphorylation [33].”
ResultOkadaic acid–induced apoptosis in malignant glioma cells
Rami, B. G., Chin, L. S., Lazio, B. E., & Singh, S. K. (2003) · Neurosurgical FOCUS · doi:10.3171/foc.2003.14.2.5 · Cited by 15
Zhang, R., Li, X., Wei, L., Qin, Y., & Fang, J. S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.011 · Cited by 15
Johannessen, M., Olsen, P. A., Johansen, B., Seternes, O. M., & Moens, U. L. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00071-6 · Cited by 15
Johannessen, M., Olsen, P. A., Sørensen, R., Johansen, B., Seternes, O. M., & Moens, U. L. (2003) · Journal of General Virology · doi:10.1099/vir.0.19057-0 · Cited by 14
“…PP2A and st-ag inhibits PP2A, it is generally assumed that a major mechanism by which st-ag induces NF k B-and Sp1-dependent transcription relies on prevention of PP2A-mediated dephosphorylation of these transcription factors (Yamashita et al. , 1999; Yang et al. , 2001; Lacroix et al. , 2002).”
Tanaka, H., Yoshida, K., Okamura, H., Morimoto, H., Nagata, T., & Haneji, T. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.2.389 · Cited by 13
Metadata
- Authors
- Yang, J., Fan, G.-H., Wadzinski, B. E., Sakurai, H., & Richmond, A.
- Affiliations
- Vanderbilt University (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Richmond, Ann
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 276
- Issue
- 51
- Pages
- 47828-47833
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2665282
- OpenAlex
- W1523852619
- Cited by
- 130
- References
- 51
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 8 · 2018: 1 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 9 · 2012: 2
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6877 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 34590, CA56740, CA68485, R01CA034590, R01CA056704, P30CA068485)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- protein phosphatase 2A, RelA, NF-κB, dephosphorylation, PP2A catalytic subunit, protein-protein interaction, melanocytes, melanoma, IκB kinase, sulindac, interleukin-1, okadaic acid
- MeSH terms
- Humans, Ligases, Melanoma, Phosphoprotein Phosphatases, Phosphorylation, Protein Binding, Tumor Cells, Cultured, NF-kappa B, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.